Sanofi is trading 4.5% down at €76.34 on profit-taking following a sharp pullback from its recent rebound toward the upper end of its 52-week range.

  • The move appears to be driven by normal market volatility, as there is no fresh company-specific news or earnings catalyst in the latest coverage.
  • The downward pressure occurs despite a generally firm environment for healthcare stocks and slightly stronger global equity futures.